Literature DB >> 11371665

Evaluation of functional ability of Thai patients with rheumatoid arthritis by the use of a Thai version of the Health Assessment Questionnaire.

M Osiri1, U Deesomchok, P Tugwell.   

Abstract

METHODS: The Health Assessment Questionnaire (HAQ) was translated into Thai and its validity and applicability were assessed in 22 Thai patients with active rheumatoid arthritis (RA) before and after 6 months of treatment with disease-modifying anti-rheumatic drugs (DMARDs). The activities in three subcategories of the Thai HAQ were modified, including Eating, Hygiene and ACTIVITIES: Two common activities in Thai people were incorporated into the items in the Grip and Arising domains.
RESULTS: Significant improvements in mean HAQ scores and other parameters were observed after DMARD therapy. Mean HAQ scores correlated significantly with tender joint count, patient global and physician global assessments, and grip strength.
CONCLUSIONS: The Thai HAQ met validity requirements and can be used in the measurement of functional capacity of Thai RA patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11371665     DOI: 10.1093/rheumatology/40.5.555

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  12 in total

1.  Associations of rheumatoid factor and anti-citrullinated peptide antibody with disease progression and treatment outcomes in patients with rheumatoid arthritis.

Authors:  Wanruchada Katchamart; Ajchara Koolvisoot; Emvalee Aromdee; Praveena Chiowchanwesawakit; Chayawee Muengchan
Journal:  Rheumatol Int       Date:  2015-04-23       Impact factor: 2.631

2.  Disease activity and functional changes of RA patients receiving different DMARDs in clinical practice.

Authors:  Manathip Osiri; Utis Deesomchok; Peter Tugwell
Journal:  Clin Rheumatol       Date:  2005-12-20       Impact factor: 2.980

3.  Correlation of delta high-resolution computed tomography (HRCT) score with delta clinical variables in early systemic sclerosis (SSc) patients.

Authors:  Suparaporn Wangkaew; Juntima Euathrongchit; Pittaporn Wattanawittawas; Nuntana Kasitanon
Journal:  Quant Imaging Med Surg       Date:  2016-08

4.  Health Equity Considerations for Developing and Reporting Patient-reported Outcomes in Clinical Trials: A Report from the OMERACT Equity Special Interest Group.

Authors:  Jennifer Petkovic; Jennifer L Barton; Caroline Flurey; Niti Goel; Christie M Bartels; Cheryl Barnabe; Maarten P T de Wit; Anne Lyddiatt; Diane Lacaille; Vivian Welch; Annelies Boonen; Beverley Shea; Robin Christensen; Lara J Maxwell; Willemina Campbell; Janet Jull; Karine Toupin-April; Jasvinder A Singh; Charles H Goldsmith; Antoine G Sreih; Christoph Pohl; Catherine Hofstetter; Dorcas E Beaton; Rachelle Buchbinder; Francis Guillemin; Peter S Tugwell
Journal:  J Rheumatol       Date:  2017-02-15       Impact factor: 4.666

5.  The association between 10-year fracture risk by FRAX and osteoporotic fractures with disease activity in patients with rheumatoid arthritis.

Authors:  Ratanapha Phuan-Udom; Nittaya Lektrakul; Wanruchada Katchamart
Journal:  Clin Rheumatol       Date:  2018-07-23       Impact factor: 2.980

6.  Cross-cultural adaptation and validation of the Thai version of the Rheumatoid Arthritis Disease Activity Index (RADAI).

Authors:  Wanruchada Katchamart; Prapassorn Ussavasodhi; Praveena Chiowchanwesawakit; Wanwisa Chanapai
Journal:  Rheumatol Int       Date:  2013-04-16       Impact factor: 2.631

7.  Psychometric evaluation of a Moroccan version of health assessment questionnaire for use in Moroccan patients with rheumatoid arthritis.

Authors:  Fatima Ezzahra Abourazzak; Karima Benbouazza; Bouchra Amine; Rachid Bahiri; Noufissa Lazrak; Fatiha Bzami; Imane Jroundi; Redouane Abouqal; Francis Guillemin; Najia Hajjaj-Hassouni
Journal:  Rheumatol Int       Date:  2008-06-06       Impact factor: 2.631

8.  Cost effectiveness analysis of disease modifying antirheumatic drugs in rheumatoid arthritis.

Authors:  Manathip Osiri; Pirom Kamolratanakul; Andreas Maetzel; Peter Tugwell
Journal:  Rheumatol Int       Date:  2007-04-14       Impact factor: 2.631

9.  Causes of death, survival and risk factors of mortality in Thai patients with early systemic sclerosis: inception cohort study.

Authors:  Suparaporn Wangkaew; Narawudt Prasertwitayakij; Arintaya Phrommintikul; Saowanee Puntana; Juntima Euathrongchit
Journal:  Rheumatol Int       Date:  2017-10-12       Impact factor: 2.631

10.  Comprehensibility, reliability, validity, and responsiveness of the Thai version of the Health Assessment Questionnaire in Thai patients with rheumatoid arthritis.

Authors:  Manathip Osiri; Jeerapat Wongchinsri; Sitthichai Ukritchon; Punchong Hanvivadhanakul; Nuntana Kasitanon; Boonjing Siripaitoon
Journal:  Arthritis Res Ther       Date:  2009-08-27       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.